Could a simple pill calm brain inflammation and slow Alzheimer's?

NCT ID NCT04804241

Recruiting now Disease control Sponsor: University of California, Davis Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental drug called senicapoc in people with mild Alzheimer's or mild cognitive impairment. The goal is to see if it can reduce brain inflammation and slow down memory loss. About 55 participants will take either the drug or a placebo for 52 weeks, with regular tests of thinking skills and spinal fluid markers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE MILD COGNITIVE IMPAIRMENT

Contacts and locations

Locations

UC Davis Alzheimer's Disease Center East Bay
RECRUITING

Walnut Creek, California, 94598, United States
University of California, Davis Alzheimer's Disease Center
RECRUITING

Sacramento, California, 95817, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.